In this episode, Dr. Bob Schafer, CEO of Lumos Labs, discusses the company's evolution from the popular brain training platform, Lumosity, to a leader in the development of digital therapeutics for the brain. Lumos Labs is pioneering the use of science-backed gameplay to tackle cognitive issues associated with conditions like ADHD.
We discuss:
- The unique dataset behind Lumosity, with over 100 million users and 8 billion gameplays
- How their extensive research fueled the shift towards digital therapeutics
- Challenges faced by early digital therapeutic companies, and the need for adaptable business models
- Lumos Labs' approach to commercialization and ensuring accessibility
- The future of digital health and medicine in addressing brain health and cognitive function
